Del i serien Advances in Biochemical Engineering/Biotechnology

New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins

Inbunden, Engelska, 2018

AvBob Kiss,Uwe Gottschalk,Michael Pohlscheidt

5 029 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This book review series presents current trends in modern biotechnology. Special volumes are dedicated to selected topics which focus on new biotechnological products and new processes for their synthesis and purification. In general, special volumes are edited by well-known guest editors.

Produktinformation

Utgivningsdatum2018-12-17
Mått155 x 235 x 31 mm
Vikt875 g
FormatInbunden
SpråkEngelska
SerieAdvances in Biochemical Engineering/Biotechnology
Antal sidor469
Upplaga18001
FörlagSpringer International Publishing AG
ISBN9783319971087

Tillhör följande kategorier

Kemi inom Naturvetenskap och teknik
Biokemisk teknik inom Naturvetenskap och teknik

Market and Capacity evolvement of the Biopharmaceutical Industry.- New Mammalian Expression Systems.- Innovation in seed train cultivation and production culture.- Manufacturing of Proteins and Antibodies / Risk mitigation for the contamination by adventitious agents.- Harvest operations.- Downstream Processing Technologies / Capturing and Final Purifaction.- Fully disposable manufacturing concepts for clinical and commercial manufacturing and Ballroom Concepts.- Augmented Reality – PAT and Artificial Intelligence for innovative process monitoring and controls.- Trends and innovations in formulations, fill and finish technologies and drug delivery.- Process Integration towards continuous manufacturing.- Future direction of Manufacturing of novel molecular format - a research perspective (bispecific antibodies, ADC, Ab fragments, fusion proteins, etc.- Cell therapy manufacturing for modern therapeutics.- Gene therapy.- Modern technologies and strategies for vaccine manufacturing.- Product and Technology Lifecycle Management in the Pharmaceutical Industry.- Integrated High Throughput Development.- A different perspective – How much innovation is really needed for production of mAb by mammalian cell technology?